Generating a robust prediction model for stage I lung adenocarcinoma recurrence after surgical resection

Lung cancer mortality remains high even after successful resection. Adjuvant treatment benefits stage II and III patients, but not stage I patients, and most studies fail to predict recurrence in stage I patients. Our study included 211 lung adenocarcinoma patients (stages I–IIIA; 81% stage I) who r...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yu-Chung, Wei, Nien-Chih, Hung, Jung-Jyh, Yeh, Yi-Chen, Su, Li-Jen, Hsu, Wen-Hu, Chou, Teh-Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668084/
https://www.ncbi.nlm.nih.gov/pubmed/29108351
http://dx.doi.org/10.18632/oncotarget.19161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668084/
https://www.ncbi.nlm.nih.gov/pubmed/29108351
http://dx.doi.org/10.18632/oncotarget.19161

Ejemplares similares